Recursion Pharmaceuticals shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $688k | 141k | 4.88 |
| 2025-06-30 | $644k | 127k | 5.06 |
| 2025-03-31 | $620k | 117k | 5.29 |
| 2024-12-31 | $595k | 88k | 6.76 |
| 2024-09-30 | $524k | 80k | 6.58 |
| 2024-06-30 | $577k | 77k | 7.50 |
| 2024-03-31 | $699k | 70k | 9.97 |
| 2023-12-31 | $631k | 64k | 9.86 |
| 2023-09-30 | $458k | 60k | 7.65 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors